Type 2 diabetes mellitus (T2DM) is recognized for increasing the risk of dementia; however, conclusive evidence supporting interventions to mitigate this risk remains elusive. This study endeavours to ascertain whether… Click to show full abstract
Type 2 diabetes mellitus (T2DM) is recognized for increasing the risk of dementia; however, conclusive evidence supporting interventions to mitigate this risk remains elusive. This study endeavours to ascertain whether the glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) correlate with reduced incidence of dementia.
Keywords:
like peptide;
diabetes mellitus;
type diabetes;
receptor agonists;
peptide receptor;
glucagon like
Journal Title: Diabetes/Metabolism Research and Reviews
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes/Metabolism Research and Reviews
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!